Research of Exenatide for Management of Reproductive and Metabolic Dysfunction in Overweight/Obese PCOS Patients With Impaired Glucose Regulation
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Exenatide (Primary) ; Metformin
- Indications Obesity; Overweight
- Focus Therapeutic Use
- 29 Sep 2020 Results published in the Journal of Clinical Endocrinology and Metabolism
- 09 Sep 2019 Status changed from recruiting to completed.
- 28 Nov 2017 Status changed from not yet recruiting to recruiting.